Dalfampridine effects on cognition, fatigue, and dexterity

OBJECTIVES: Dalfampridine exerts beneficial effects on walking ability in a subgroup of patients with multiple sclerosis (MS). These patients are termed “responders”. Here, we investigated whether the responder status with respect to mobility measures would determine whether dalfampridine treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Korsen, Melanie, Kunz, Rhina, Schminke, Ulf, Runge, Uwe, Kohlmann, Thomas, Dressel, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256171/
https://www.ncbi.nlm.nih.gov/pubmed/28127507
http://dx.doi.org/10.1002/brb3.559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256171/
https://www.ncbi.nlm.nih.gov/pubmed/28127507
http://dx.doi.org/10.1002/brb3.559

Ejemplares similares